Skip to main content
1-800-833-0680NET 30 Available

Magenta product comparison

Magenta 12-panel cup vs dip card

Same 12-analyte panel, same CLIA waiver, two collection workflows — how the format choice changes per-test cost, training, and operational throughput.

The short answer

Both formats screen the same 12 substances and carry the same FDA clearance and CLIA waiver — the difference is workflow. The integrated cup (clicker or tapered) lets the donor void directly into the device that runs the test, eliminating specimen transfer and reducing chain-of-custody steps. The dip card requires the donor to void into a separate collection cup, after which the collector dips the card into the specimen. Cups are faster end-to-end, cleaner from a chain-of-custody standpoint, and easier for less-experienced collectors. Dip cards cost meaningfully less per test, take less storage space, and let one collection cup feed multiple panels if you need a custom configuration. For most clinical and rehab settings, the integrated cup is the right default. For pre-employment testing at scale, mobile collection units, and programs that need configurable panels, the dip card wins on flexibility and unit cost.

Side-by-side comparison

Analytes screened

Magenta 12-panel cup
12 (same panel)
Magenta 12-panel dip card
12 (same panel)

FDA-cleared (Class II)

Magenta 12-panel cup
Yes
Magenta 12-panel dip card
Yes

CLIA-waived

Magenta 12-panel cup
Yes
Magenta 12-panel dip card
Yes

Specimen collection

Magenta 12-panel cup
Donor voids directly into test device
Magenta 12-panel dip card
Donor voids into separate cup; collector dips card

Workflow steps

Magenta 12-panel cup
Collect → seal → read
Magenta 12-panel dip card
Collect → transfer/dip → read

Integrated temperature strip

Magenta 12-panel cup
Yes (most SKUs)
Magenta 12-panel dip card
On the dip card body, not the collection cup

Per-test cost tier

Magenta 12-panel cup
Premium
Magenta 12-panel dip card
Standard

Storage / shipping footprint

Magenta 12-panel cup
Larger — bulkier per 100
Magenta 12-panel dip card
Smaller — compact pouches

Configurable panels from one specimen

Magenta 12-panel cup
No — one cup, one panel
Magenta 12-panel dip card
Yes — multiple cards from one specimen

Best for

Magenta 12-panel cup
Clinical, rehab, forensic, chain-of-custody-sensitive
Magenta 12-panel dip card
Pre-employment, mobile collection, cost-sensitive scale

Magenta 12-panel CLIA-waived cup

Integrated specimen-and-test cup — donor voids into the same vessel that runs the 12-analyte screen. Available in clicker (key-activated) and tapered (gravity-flow) mechanisms.

Strengths

  • +Single-step collection — no specimen transfer between containers
  • +Cleaner chain-of-custody — specimen and result are in one sealed vessel
  • +Integrated temperature strip confirms specimen validity at collection
  • +Easier for less-experienced collectors — fewer manual steps
  • +Clicker variant lets the collector control when the read window starts

Limitations

  • Higher per-test cost than a dip card screening the same panel
  • Bulkier — more shipping and storage volume per 100 tests
  • Fixed panel — one cup runs one configuration

Best for

  • Clinical and outpatient settings with fixed workflows
  • Rehab intake and addiction medicine
  • Court-ordered and forensic testing where chain-of-custody matters
  • Programs with rotating or junior collectors

The integrated cup is what most clinical buyers picture when they think 'drug test.' The donor receives a sealed cup, voids into it, hands it back, and the collector reads the result on the cup's side panel — typically within five minutes of collection. There is no separate specimen container, no pipette, no second device to handle.

Operationally, that integration matters most in two places. First, chain of custody: a single sealed vessel that contains both the specimen and the result is easier to document and defend than a workflow where a specimen has been transferred between containers. For court-ordered testing, sober-living programs, and any context where a positive result may need to be defended in a hearing, the integrated cup removes a category of process objections.

Second, collector training: the integrated workflow has fewer manual steps than dipping a card into a separate cup. New collectors, per-diem clinicians, and cross-trained medical assistants can be brought up to competency on cups faster than on dip cards, and the consistency of the workflow reduces the rate of invalid or compromised results in real-world use.

The cost premium is real. A 12-panel cup typically runs meaningfully more per unit than a 12-panel dip card from the same family. For a clinic running a few dozen tests per month, the dollar gap is rounding. For a program running thousands per month, it adds up — and at that volume, you should price both formats from us before deciding. The right answer is rarely 'always the cup' or 'always the card'; it is matching format to workflow.

Magenta 12-panel CLIA-waived dip card

Lateral-flow dip card screening the same 12 analytes — donor voids into a separate collection cup, collector dips the card strips into the specimen and reads the result.

Strengths

  • +Lowest per-test cost in the 12-panel family
  • +Compact — fits in glovebox or field kit
  • +One collection cup can feed multiple dip cards for custom panels
  • +Ideal for mobile and field collection
  • +Lower shipping and storage cost per 100 tests

Limitations

  • Two-step workflow — separate collection cup plus card
  • Requires a separate temperature-validation step if specimen validity matters
  • More handling — slightly higher contamination and spill risk
  • Chain-of-custody requires documenting the specimen-to-card transfer

Best for

  • High-volume pre-employment screening
  • Mobile collection units and on-site employer programs
  • Field harm-reduction and community health
  • Programs running configurable panels from one specimen
  • Cost-sensitive procurement at scale

The dip card is the older format, and that is not a knock — it is the format that grew up alongside the workplace drug-testing industry in the 1990s and 2000s, and it is still the dominant format for high-volume employer screening for good reasons.

The collection cup is separate from the test, which means the same specimen can feed multiple cards if you need a configuration that no single integrated cup offers. If you run a pre-employment program that screens 12 analytes for office workers and adds adulteration detection for safety-sensitive roles, two dip cards from one specimen is cheaper and faster than two different integrated cups.

Mobile and field collection is where dip cards really win. They pack flatter, weigh less, and store more compactly than cups — useful for employer wellness vans, occupational-health field teams, and community-based harm-reduction programs. The unit-cost gap is also widest at the volumes these programs run.

The operational tradeoff is collector handling. A dip card workflow has one more step than an integrated cup, and that step — transferring or dipping into the specimen — is where the workflow is most likely to be done inconsistently by a junior collector. Programs that go with dip cards should invest in a simple collector protocol and a 15-minute training video; programs that cannot make that investment may be better served by cups even at the higher unit cost.

How to choose

Start with chain-of-custody requirements. If a positive result in your program may need to be defended in a hearing — court-ordered abstinence monitoring, professional licensing, sober-living violations — the integrated cup removes a process objection that dip cards introduce. The single sealed vessel that holds both the specimen and the result is the simpler story to defend.

Match the format to your collector profile. Integrated cups are faster to train on and more forgiving of inconsistent execution. Dip cards reward a trained, repeatable collector workflow and can produce more variable results in the hands of rotating or under-trained staff. If your collectors are full-time clinicians, either format works. If they include per-diem staff or non-medical employees doing pre-employment screening, the cup is usually the safer choice.

Run the math on your actual volume. The per-test cost gap is real but small relative to the cost of a re-collection, a confirmation send-out, or a chain-of-custody dispute. For programs at the 100-test-per-month tier, format choice is dominated by workflow fit, not unit price. For programs at the 10,000-test-per-month tier, the unit-cost gap can fund a meaningful improvement somewhere else — collector training, EMR integration, faster lab confirmation — that delivers more value than the format premium.

Questions to ask

  • Does a positive result in your program ever need to be defended formally?
  • Are your collectors full-time medical staff or rotating non-medical employees?
  • Do you run one fixed panel, or do you need configurable panels from one specimen?
  • Is your collection setting fixed (clinic) or mobile (field, employer site)?
  • What is your annual volume, and what is the actual per-test cost gap at that volume?

Recommendation by use case

Clinical and outpatient testing
Integrated cup — chain-of-custody and workflow simplicity win.
Addiction medicine and MAT
Integrated cup — clinical context favors the cleaner workflow.
Rehab intake (high throughput)
Integrated cup, clicker variant — read-window control matters when multiple donors arrive together.
Pre-employment screening (high volume)
Dip card — unit cost and compactness win at scale.
Mobile collection units
Dip card — pack and storage footprint matters in the field.
Court-ordered or forensic testing
Integrated cup — defensible chain-of-custody.
Programs needing configurable panels
Dip card — multiple cards from one specimen is unique to this format.
Sober-living monthly testing
Integrated cup if chain-of-custody matters; dip card if cost-sensitive.

We stock both formats at the same 12-analyte panel so procurement can pilot side by side. Volume pricing applies at 100 units across either format.

Frequently asked questions

Are the cup and dip card equally accurate?+

Yes — both formats use the same lateral-flow immunoassay chemistry on the same 12 analytes and carry the same FDA Class II clearance and CLIA waiver. Read within the manufacturer-specified window (typically five minutes), the two formats produce equivalent results.

Can I use one collection cup for multiple dip cards?+

Yes — that is one of the dip card's structural advantages. A single specimen of sufficient volume can feed several dip cards if you need to run a panel configuration that no single integrated cup offers (for example, a 12-panel card plus a separate fentanyl or adulteration card).

Which format is better for DOT testing?+

Neither format is used as the primary test in DOT-regulated drug testing. DOT-regulated testing under 49 CFR Part 40 requires laboratory testing at an HHS-certified laboratory using the federal chain-of-custody form (CCF) and the specimen-collection containers specified in Part 40 — instant point-of-care immunoassay cups, ours or anyone's, are not the primary regulated test. Both formats are appropriate for non-regulated employer screening, pre-employment programs that sit outside the DOT framework, clinical use, and any program where DOT Part 40 does not apply. If your program is DOT-regulated, work with your DOT-qualified TPA and confirm collection-container and lab requirements with them before procurement.

How does chain-of-custody differ between the two formats?+

The integrated cup keeps the specimen and the result in a single sealed vessel for the life of the test, which simplifies the chain-of-custody documentation. The dip card workflow requires documenting the specimen transfer from collection cup to test card; this is straightforward but is one additional step that needs to be captured on the chain-of-custody form.

Which format costs less per test?+

The dip card is consistently lower per unit than the integrated cup at the same panel size. The exact gap depends on order volume — we are happy to quote both formats together at your projected annual volume so you can compare apples to apples.

Sources

  1. FDA. FDA — Drugs of abuse tests
  2. SAMHSA. SAMHSA — Drug-free workplace
  3. SAMHSA. SAMHSA — Federal laws and regulations on workplace drug testing
  4. DOT. DOT — 49 CFR Part 40
  5. CDC. CDC — NIOSH (workplace safety and health)

Want to pilot both formats at the same panel?

Procurement teams find their answer fastest by running 50 of each through their actual workflow for a week. We will set you up with matching 12-panel cups and dip cards at quote pricing.

Request a quote